| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |